Related Experiment Video
Updated: Jan 8, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
"Hadrontherapy for Life" Symposium, Caen, March 10/11, 2025-Strategy for the Future-Pancreatic Cancer
Jean-Louis Habrand1, Siamak Haghdoost2, Semi B Harrabi3
1Radiation Oncology Department, François Baclesse Cancer Center, Caen, France.
International Journal of Particle Therapy
|December 24, 2025
Summary
Heavy ions particle therapy, particularly carbon ion radiotherapy (CIRT), shows promise for pancreatic cancer. Experts discussed its role in advanced and preoperative settings with acceptable toxicity, and potential combination with other therapies.
Area of Science:
- Oncology
- Radiotherapy
- Medical Physics
Background:
- Pancreatic cancer is a leading cause of cancer mortality, necessitating advanced treatment strategies.
- Heavy ions particle therapy, specifically carbon ion radiotherapy (CIRT), is an evolving treatment modality.
- International experts convened to discuss the clinical and biological aspects of CIRT.
Purpose of the Study:
- To review current indications and future strategies for heavy ions particle therapy.
- To prioritize the role of CIRT in managing pancreatic cancer.
- To explore the potential of CIRT in combination with other therapies.
Main Methods:
- Symposium involving over 100 international experts in heavy ions particle therapy.
- Discussion of clinical data and biological rationale for CIRT.
- Focus on advanced and preoperative settings for pancreatic cancer treatment.
Main Results:
- Clinical data suggest CIRT plays a significant role in advanced pancreatic cancer.
- CIRT demonstrates efficacy in a preoperative setting with acceptable toxicity.
- Biological factors support combining CIRT with bio or immune therapies.
Conclusions:
- Carbon ion radiotherapy (CIRT) is a promising treatment for pancreatic cancer.
- CIRT offers a viable option for both advanced and neoadjuvant treatment of pancreatic cancer.
- Future research should explore combinations of CIRT with immunotherapy and targeted agents.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:29Chronic Pancreatitis II: Collaborative Care
284
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
284